Fig. 4From: The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytesqPCR validation of differential expression of RGS4, EGR1, SLC6A6 and PHLDA1 by trastuzumab and lapatinib in iPSC-derived cardiomyocytes. Standard deviation (SD) calculated from three replicates. Down-regulation of: a RGS4, b SLC6A6, c EGR1 and d PHLDA1 by trastuzumab and lapatinib was confirmed by qPCR. Student’s T-test, unequal values, p < 0.05*; p < 0.01**Back to article page